Literature DB >> 11143270

Stereotactic radiosurgery versus stereotactic radiotherapy for patients with vestibular schwannoma: a Leksell Gamma Knife Society 2000 debate.

M E Linskey1.   

Abstract

By definition, the term "radiosurgery" refers to the delivery of a therapeutic radiation dose in a single fraction, not simply the use of stereotaxy. Multiple-fraction delivery is better termed "stereotactic radiotherapy." There are compelling radiobiological principles supporting the biological superiority of single-fraction radiation for achieving an optimal therapeutic response for the slowly proliferating, late-responding, tissue of a schwannoma. It is axiomatic that complication avoidance requires precise three-dimensional conformality between treatment and tumor volumes. This degree of conformality can only be achieved through complex multiisocenter planning. Alternative radiosurgery devices are generally limited to delivering one to four isocenters in a single treatment session. Although they can reproduce dose plans similar in conformality to early gamma knife dose plans by using a similar number of isocenters, they cannot reproduce the conformality of modern gamma knife plans based on magnetic resonance image-targeted localization and five to 30 isocenters. A disturbing trend is developing in which institutions without nongamma knife radiosurgery (GKS) centers are championing and/or shifting to hypofractionated stereotactic radiotherapy for vestibular schwannomas. This trend appears to be driven by a desire to reduce complication rates to compete with modern GKS results by using complex multiisocenter planning. Aggressive advertising and marketing from some of these centers even paradoxically suggests biological superiority of hypofractionation approaches over single-dose radiosurgery for vestibular schwannomas. At the same time these centers continue to use the term radiosurgery to describe their hypofractionated radiotherapy approach in an apparent effort to benefit from a GKS "halo effect." It must be reemphasized that as neurosurgeons our primary duty is to achieve permanent tumor control for our patients and not to eliminate complications at the expense of potential late recurrence. The answer to minimizing complications while maintaining maximum tumor control is improved conformality of radiosurgery dose planning and not resorting to homeopathic radiosurgery doses or hypofractionation radiotherapy schemes.

Entities:  

Mesh:

Year:  2000        PMID: 11143270     DOI: 10.3171/jns.2000.93.supplement

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  10 in total

Review 1.  Stereotactic radiosurgery of benign intracranial tumors.

Authors:  Bruce E Pollock
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

2.  The impact of MRI steady-state sequences as an additional assessment modality in vestibular schwannoma patients after LINAC stereotactic radiotherapy or radiosurgery.

Authors:  Julian P Sauer; Thomas M Kinfe; Bogdan Pintea; Andreas Schäfer; Jan P Boström
Journal:  Strahlenther Onkol       Date:  2018-05-23       Impact factor: 3.621

Review 3.  Does Proton Therapy Have a Future in CNS Tumors?

Authors:  Stephanie E Combs
Journal:  Curr Treat Options Neurol       Date:  2017-03       Impact factor: 3.598

4.  3D quantitative assessment of response to fractionated stereotactic radiotherapy and single-session stereotactic radiosurgery of vestibular schwannoma.

Authors:  T Schneider; J Chapiro; M Lin; J F Geschwind; L Kleinberg; D Rigamonti; I Jusué-Torres; A E Marciscano; D M Yousem
Journal:  Eur Radiol       Date:  2015-07-03       Impact factor: 5.315

Review 5.  Stereotactic radiosurgery for patients with cancer of the head and neck.

Authors:  Edward Gardner; Mark E Linskey; José A Peñagarícano; Ehab Y Hanna
Journal:  Curr Oncol Rep       Date:  2003-03       Impact factor: 5.075

Review 6.  The evolving role of stereotactic radiosurgery for patients with skull base tumors.

Authors:  Bruce E Pollock; Robert L Foote
Journal:  J Neurooncol       Date:  2004 Aug-Sep       Impact factor: 4.130

7.  A mechanistic mathematical model of initiation and malignant transformation in sporadic vestibular schwannoma.

Authors:  Chay Paterson; Ivana Bozic; Miriam J Smith; Xanthe Hoad; D Gareth R Evans
Journal:  Br J Cancer       Date:  2022-09-12       Impact factor: 9.075

8.  Moderately Hypofractionated Radiation for Benign Meningiomas and Schwannomas: A Report of 70 Patients Treated Between 2008 and 2018.

Authors:  Vishal R Dhere; Sibo Tian; Zachary Buchwald; Xiaojun Jiang; Chao Zhang; Zhengjia Chen; Bree R Eaton; Hui-Kuo G Shu; Walter J Curran; Jim Zhong
Journal:  Adv Radiat Oncol       Date:  2020-09-28

Review 9.  Facial nerve preservation after vestibular schwannoma Gamma Knife radiosurgery.

Authors:  Isaac Yang; Michael E Sughrue; Seunggu J Han; Shanna Fang; Derick Aranda; Steven W Cheung; Lawrence H Pitts; Andrew T Parsa
Journal:  J Neurooncol       Date:  2009-05-09       Impact factor: 4.130

10.  The new SRS/FSRT technique HyperArc for benign brain lesions: a dosimetric analysis.

Authors:  Hsiu-Wen Ho; Ching-Chieh Yang; Hsiu-Man Lin; Hsiao-Yun Chen; Chun-Chiao Huang; Shih-Chang Wang; Yu-Wei Lin
Journal:  Sci Rep       Date:  2021-10-26       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.